ArticleProceedings of the National Academy of Sciences of the United States of America2026

Correction for Yang et al., Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.